Inventor · disambiguated record
Alain Delcayre
Also filed as: DELCAYRE ALAIN
14 granted patents·5 pending applications·104 citations·filing 1999–2021
90Inventor score
Files withGENESIS RES & DEV CORP LTD6BAVARIAN NORDIC AS3BN IMMUNOTHERAPEUTICS INC3DELCAYRE ALAIN2EXOTHERA L L C2
Top patents by PatentIndex Score
19 records- 0193US7807146B2Methods for treating cancer with a recombinant MVA expressing HER-2BN IMMUNOTHERAPEUTICS INC·Filed 2007·Granted Oct 5, 2010·18 cites·25 claims
- 0292US8377688B2Use of MVA to treat prostate cancerBN IMMUNOTHERAPEUTICS INC·Filed 2010·Granted Feb 19, 2013·26 cites·23 claims
- 0391US7867483B2Use of MVA to treat prostate cancerBN IMMUNOTHERAPEUTICS INC·Filed 2008·Granted Jan 11, 2011·15 cites·13 claims
- 0487US7704964B2Methods and compounds for the targeting of protein to exosomesEXOTHERA L L C·Filed 2002·Granted Apr 27, 2010·34 cites·38 claims
- 0581US8313740B2Methods for treating cancer with a recombinant MVA expressing HER-2DELCAYRE ALAIN·Filed 2010·Granted Nov 20, 2012·5 cites·56 claims
- 0667US7914792B2Methods and compounds for raising antibodies and for screening antibody repertoiresEXOTHERA L L C·Filed 2004·Granted Mar 29, 2011·1 cites·32 claims
- 0763US6716430B2Compositions isolated from M. vaccae and their use in the modulation of immune responsesGENESIS RES & DEV CORP LTD·Filed 2002·Granted Apr 6, 2004·1 cites·11 claims
- 0862US2016271239A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint InhibitorBAVARIAN NORDIC AS·Filed 2014·Application pending·0 cites
- 0959US2021205429A1Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint InhibitorBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 1058US7192590B2Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 2003·Granted Mar 20, 2007·0 cites·4 claims
- 1153US2005214320A1Compositions isolated from M. vaccae and their use in the modulation of immune responsesGENESIS RES AND DEV CORP LIMTE·Filed 2004·Application pending·0 cites
- 1250US11753652B2Cassette encoding a FPV/brachyury fusion proteinBAVARIAN NORDIC AS·Filed 2016·Granted Sep 12, 2023·0 cites·7 claims
- 1346US7041295B2Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Granted May 9, 2006·0 cites·5 claims
- 1443US2015283220A1Methods and compositions for the treatment of cancerBAVARIAN NORDIC INC·Filed 2013·Application pending·0 cites
- 1542US11517530B2Therapeutic agents specifically delivered by exosomes for cancer treatmentUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Dec 6, 2022·0 cites·12 claims
- 1638US6436898B1Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 1999·Granted Aug 20, 2002·2 cites·27 claims
- 1738US6361776B1Compounds isolated from M. vaccae and their use in modulation of immune responsesGENESIS RES & DEV CORP LTD·Filed 1999·Granted Mar 26, 2002·2 cites·12 claims
- 1838US2009148460A1Exosome ligands, their preparation and usesDELCAYRE ALAIN·Filed 2006·Application pending·0 cites
- 1932US6358734B1Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 1999·Granted Mar 19, 2002·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Alain Delcayre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →